Search Results - "Howard, Scott C."

Refine Results
  1. 1

    Preventing and Managing Toxicities of High‐Dose Methotrexate by Howard, Scott C., McCormick, John, Pui, Ching‐Hon, Buddington, Randall K., Harvey, R. Donald

    Published in The oncologist (Dayton, Ohio) (01-12-2016)
    “…High‐dose methotrexate (HDMTX), defined as a dose higher than 500 mg/m2, is used to treat a range of adult and childhood cancers. Although HDMTX is safely…”
    Get full text
    Journal Article
  2. 2

    Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers by Dunnenberger, Henry M, Crews, Kristine R, Hoffman, James M, Caudle, Kelly E, Broeckel, Ulrich, Howard, Scott C, Hunkler, Robert J, Klein, Teri E, Evans, William E, Relling, Mary V

    “…Although the field of pharmacogenetics has existed for decades, practioners have been slow to implement pharmacogenetic testing in clinical care. Numerous…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Current management and challenges of malignant disease in the CNS in paediatric leukaemia by Pui, Ching-Hon, Prof, Howard, Scott C, MD

    Published in The lancet oncology (01-03-2008)
    “…Summary With 5-year event-free survival of 80% now commonplace for paediatric acute lymphoblastic leukaemia (ALL), and 50% for paediatric acute myeloid…”
    Get full text
    Journal Article
  5. 5

    Paediatric cancer in low-income and middle-income countries by Magrath, Ian, Prof, Steliarova-Foucher, Eva, PhD, Epelman, Sidnei, MD, Ribeiro, Raul C, Prof, Harif, Mhamed, Prof, Li, Chi-Kong, Prof, Kebudi, Rejin, Prof, Macfarlane, Scott D, MBChB, Howard, Scott C, Prof

    Published in The lancet oncology (01-03-2013)
    “…Summary Patterns of cancer incidence across the world have undergone substantial changes as a result of industrialisation and economic development. However,…”
    Get full text
    Journal Article
  6. 6

    Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low- and middle-income countries by Gupta, Sumit, Rivera-Luna, Roberto, Ribeiro, Raul C, Howard, Scott C

    Published in PLoS medicine (01-06-2014)
    “…Dr. Sumit Gupta and colleagues discuss the need for national cancer strategies for children in low- and middle-income countries and suggest how such strategies…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Management of occlusion and thrombosis associated with long-term indwelling central venous catheters by Baskin, Jacquelyn L, MD, Pui, Ching-Hon, Prof, Reiss, Ulrike, MD, Wilimas, Judith A, MD, Metzger, Monika L, MD, Ribeiro, Raul C, MD, Howard, Scott C, Dr

    Published in The Lancet (British edition) (11-07-2009)
    “…Summary Long-term central venous catheters (CVCs) are important instruments in the care of patients with chronic illnesses, but catheter occlusions and…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Reported availability and gaps of pediatric palliative care in low- and middle-income countries: a systematic review of published data by Caruso Brown, Amy E, Howard, Scott C, Baker, Justin N, Ribeiro, Raul C, Lam, Catherine G

    Published in Journal of palliative medicine (01-12-2014)
    “…The majority of young people in need of palliative care live in low- and middle-income countries, where curative treatment is less available. We systematically…”
    Get more information
    Journal Article
  19. 19

    Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia by Kawedia, Jitesh D., Liu, Chengcheng, Pei, Deqing, Cheng, Cheng, Fernandez, Christian A., Howard, Scott C., Campana, Dario, Panetta, John C., Bowman, W. Paul, Evans, William E., Pui, Ching-Hon, Relling, Mary V.

    Published in Blood (16-02-2012)
    “…We have previously hypothesized that higher systemic exposure to asparaginase may cause increased exposure to dexamethasone, both critical chemotherapeutic…”
    Get full text
    Journal Article
  20. 20

    Multiple Asparaginase Infusions Cause Increasingly Severe Acute Hyperammonemia by Buddington, Randal K, Buddington, Karyl K, Howard, Scott C

    Published in Medical sciences (Basel) (12-08-2022)
    “…Adverse reactions during and shortly after infusing asparaginase for the treatment of acute lymphoblastic leukemia can increase in severity with later doses,…”
    Get full text
    Journal Article